Viral hepatitis during pregnancy is associated with higher risks of maternal complications. The epidemiology of viral hepatitis during pregnancy is essential for health planners and programme managers. This study was conducted to determine the prevalence of HBV & HCV infection in pregnant women. It was a hospital based retrospective study. During the study period; a total of 2450 pregnant females were tested for hepatitis B and C. There were 158 females with positive hepatitis results, out of which 130 were hepatitis C positive and 28 were hepatitis B positive. Only 3 females were those having both hepatitis B and C positive. Average age range of women's was 27-36 years. The data was analyzed by ICT method available at facility of (MCH).We concluded that prevalence of hepatitis B and C in pregnant women is high, of which hepatitis C is more prevalent than hepatitis B and the co-infection of hepatitis B and C was observed as well.
Introduction
Hepatitis is a medical condition defined by inflammation of the liver and characterized by the presence of inflammatory cells in the tissue of an organ. Hepatitis is caused by viruses, alcohol, toxins, drugs, autoimmune condition, metabolic diseases and pregnancy.
Viral hepatitis is caused by HAV (hepatitis A virus) HBV (hepatitis B virus) HCV (hepatitis C virus) HDV (hepatitis D virus) HEV (hepatitis E virus).
Hepatitis B virus (HBV) and hepatitis C virus (HCV) are among the principal causes of severe liver disease, including hepatocellular carcinoma and cirrhosis-related end-stage liver disease [1] .
Perinatal transmission from mother to her newborn baby is the most important mode of infection. If pregnant women is an HBV carrier and is also positive for hepatitis B 'e' antigen (HBeAg), her newborn baby has a 90% chance of becoming infected. Approximately 25% of infected infants will become chronic carriers [2] .
Hepatitis C virus (HCV) is one of major etiological agents for parenterally acquired hepatitis. It is asymptomatic in large proportion of cases (64-75%) and revealed
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accidentally by abnormal liver function tests or anti-HCV positivity. The long term morbidity and mortality is far greater than its counterpart hepatitis B virus in terms of chronic hepatitis (70%), cirrhosis (20-30%), hepatocellular carcinoma and liver function. HCV can be transmitted through various routes, like blood transfusion, reuse of syringes, organ transplantation, sexual exposure, contaminated instruments, use of multi-dose viral injections, tattooing, body piercing, parental transmission and sharing razors [3] .
Chronic hepatitis C is the primary cause of cirrhosis and liver cancer. Liver cirrhosis may lead to portal hypertension, ascites, bruising and bleeding, jaundice and hepatic encephalopathy. It is a common cause of liver transplant [4] .
In the pregnant population, the prevalence of HCV is estimated to be about 1%, with the highest prevalence in the black population 6.1% and the lowest in the Latino population 2.8%. Only 25% of pregnant women report receiving blood products' or using IV drugs when HCV infection is diagnosed. Concurrent alcoholism, IV drug use (38%), and coexisting infection with human immunodeficiency virus (HIV) (33%) are important risk factors [5, 6] .
Shams R et al. in 2010 [7] , have tested 75777 pregnant women's for hepatitis B & C. The results of healthy pregnant ladies revealed that the prevalence of both Hepatitis B and C has increased from 2002 to 2008. Prevalence of Hepatitis B increased from 1.4% to 3.4% and Hepatitis C from 6.3% to10.1%. The overall prevalence of HBsAg and HCV antibody in pregnant ladies was 1.9% and 7.4% respectively [7] .
Elsheikh RM et al. [8] have carried out a 3 months study from March-June 2006, briefly sera were collected from pregnant women at Umdurman Maternity Hospital in Sudan, and was tested for markers of hepatitis B virus (HBVsAg) and HCV. HBVsAg was detected in 41 (5.6%) out 728 women, Anti-HCV was detected in 3 (0.6%) out of 423 women's [8] . Khokhar N et, al. 2004 [9] enrolled and checked for anti HCV in all pregnant women presenting in the ante natal clinic of Shifa International Hospital Islamabad, from July 2001 to December 2002, a total of 503 patients were enrolled. 24 (4.8 %) were anti HCV positive [9] .
Keeping in view these incidences of hepatitis positive patients, the current study was carried out to determine the prevalence of HBV & HCV in pregnant women's and assess the frequency of Hepatitis B and C or co-infection among them.
Materials and Methods

Setting and Duration
The present study was carried out at the Maternal and Child Healthcare Center (MCH) of PIMS Hospital for six months.
Inclusion and Exclusion Criteria
Indore pregnant female were included while female other than this criteria were excluded for this study.
Collection of Blood Samples
Venous blood samples were collected from patients, having HBV, HCV infection. To obtain serum for the determination of HBV and HCV blood was collected in sterile, gel centrifuge tube.
Determination of HCV and HBV
The serum samples of pregnant females were analyzed to In the current study there were 158 females that revealed positive for hepatitis which is 6.45% of the total samples with a hepatitis C predominance contributing 84% and hepatitis B contributing 16%. The ratio from hepatitis B to hepatitis C was 1: 4.6. There were only 3 (1.89%) patients positive for both hepatitis B and C. Fig 4. 3 illustrates that total 158(6.45%) pregnant females were positive for hepatitis out of which 28(16%) were positive for hepatitis B, 130(84%) were positive for hepatitis C and 3(1.89%) were those having both the hepatitis B and C positive.
Discussion
Viral hepatitis B and C are the major public health concern throughout the world and is being extensively studied. Many studies have been conducted worldwide to determine the prevalence of hepatitis B and C in their general population, in healthy blood donors and among different age groups. In addition, studies have also been conducted on Hepatitis B and C among the pregnant women's.
In this study an attempt has been made to investigate the prevalence of Hepatitis B and C among healthy pregnant women's in federal capital area. The prevalence of Hepatitis B and C was following the same trend from 2002 to 2006 whereas sudden change in the trend was observed towards an increase during the last two years. This trend towards increase was probably not due to the actual rise in the burden of disease but it was most likely attributable to the difference in the allowed testing used. The testing method according to facility available is different in different year.
Pakistan is highly endemic with Hepatitis B and Hepatitis C. Studies are limited to present with a clear picture of the prevalence of Hepatitis B and Hepatitis C at the national level, especially among apparently healthy individuals. Mostly, the previous studies targeted different small groups of individuals with some clinical indications, so they do not accurately reflect the overall prevalence of Hepatitis B and C in Pakistan.
In the current study, a total of 2450 samples of the pregnant females were processed, of which 158 were positive for Hepatitis. Out of 158(6.45%) positive samples in pregnant females 28(16%) were positive for hepatitis B and 130(84%) were positive for hepatitis C. The ratio of hepatitis B and C in pregnant females was 1:4.6. And only 3(1.89%) were positive for both hepatitis B and C. The data was categorized into three age groups as Group A (17-26 yr), Group B (27-36 yr) and Group C (37-46 yr). Similar studies in 2010 by Shams R et al 2010 [7] have reported that prevalence of both Hepatitis B and C in pregnant ladies has increased from 2002 to 2008. Prevalence of Hepatitis B increased from 1.4% to 3.4% and Hepatitis C from 6.3% to 10.1%. The overall prevalence of HBsAg and HCV antibody in pregnant ladies was 1.9% and 7.4% respectively. This study revealed that Increase in seropositivity from 1.4 % to 3.4% HBV and HCV 6.3 to 10.1% from 2002 to 2008 was observed.
Another similar study Taseer et al. 2010 [10] reported that out of 500 pregnant women 35 (7.00%) were found to be anti-HCV positive and 23 (4.60%) were positive for HBsAg. Majority of the patients 263 (52.60%) were in the age group 26-35 years. Our study on pregnant women reported low prevalence of HBV and high prevalence of HCV that may be due to the poor hygienic conditions. Furthermore, Elefsiniotis et al. 2009 [11] demonstrated the overall prevalence of HBsAg among pregnant women in Greece and was estimated to be 4.1% with highest rates among Albanian immigrants 12%. Another study conducted by Lin et al in 2008 [12] [13] reported that among 3020 pregnant women, 102 were positive for HCV antibodies. Among anti-HCV positive women, 8(7.84%) were also positive for HBsAg. In 2001, Gigi RM et al. [15] reported that the prevalence of hepatitis C virus (HCV) infection was studied in 2408 pregnant women. Positive anti-HCV were detected in 47 women (1.95%). Our study on prevalence of hepatitis among pregnant women revealed high percentage which may be due to the fact that it was conducted among the people who have poor socioeconomic status and were not health conscious.
In present study the prevalence of hepatitis B is 1.14% and hepatitis C is 5.30% which is parallel with the previous studies of Pakistan 1.4-3.4% and 6.3-10.1% respectively. While the scenario in general population is also quite high (5.872% and 4.54%).In general population, the risk of transmission may be injections, razors and dental therapy while in pregnant women's risk of transmission are the instruments (used for surgical or gynecological procedures) which may be the causes of high prevalence. This study suggests that surveillance systems, monitoring policy and evaluation strategies at gross root level may improve the situation which is still very alarming and threatening.
Conclusion
Hepatitis B and C is a major public health concern and even with the implementation of interventions and health promotion strategies, it still persist at the same magnitude. Prevalence of hepatitis C virus is more common than hepatitis B virus in pregnant women's similar to prevalence in general population and though coinfection of hepatitis B and C is low but gravity of problem is double.
